Replies to post #1707 on Alexza Pharmaceuticals Inc fka ALXA

[SoonerBrn]

Yep, it looks good.

[deadjim]

charts basing, PDUFA's the catalyst.. partner lined up. no brainer.

2-4 week run starting April.

holders on PDUFA should rethink their strategy

In October 2011, we entered into a commercial partnership with Grupo Ferrer pursuant to the Ferrer Agreement to commercialize ADASUVE in Europe, Latin America, Russia and the Commonwealth of Independent States countries, or the Ferrer Territories. Under the terms of the Ferrer Agreement, in January 2012 we received an upfront cash payment of $10 million, $5 million of which was paid to the former Allegro stockholders. We are eligible to receive additional milestone payments contingent on individual country commercial sales initiation and cumulative net sales targets. We are responsible for filing and obtaining marketing authorization from the European Commission on the basis of the ADASUVE MAA submitted to the EMA. Grupo Ferrer will be responsible for satisfaction of all other regulatory and pricing reimbursement requirements to market and sell ADASUVE in the Ferrer Territories. Grupo Ferrer will have the exclusive rights to commercialize ADASUVE in the Ferrer Territories. We will supply ADASUVE to Grupo Ferrer for all of its commercial sales, and will receive a specified per-unit transfer price. Either party may terminate the Ferrer Agreement for the other party’s uncured material breach or bankruptcy. The Ferrer Agreement continues in effect on a country-by-country basis until the later of the last to expire patent covering ADASUVE in such country or 12 years after first commercial sale. The Ferrer Agreement is subject to earlier termination in the event the parties mutually agree, by a party in the event of an uncured material breach by the other party or upon the bankruptcy or insolvency of either party.
In March 2012, we entered into an amendment to the Ferrer Agreement. Grupo Ferrer and Alexza agreed to eliminate a future potential milestone payment in exchange for Grupo Ferrer’s purchase of $3 million of our common stock. Grupo Ferrer agreed to purchase approximately 2.42 million shares of our common stock for $1.24 per share in March 2012. During 2012, up to an additional $8 million of our common stock may be purchased by Grupo Ferrer, upon a request by us and subject to acceptance by Grupo Ferrer, in exchange for the elimination of additional milestones at a price per share that will be a premium to the market price on the date of purchase.